Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion type Assertion NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_head.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion description "[A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_provenance.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion evidence source_evidence_literature NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_provenance.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion SIO_000772 12890841 NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_provenance.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion wasDerivedFrom befree-2016 NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_provenance.
- NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_assertion wasGeneratedBy ECO_0000203 NP403826.RAbVfDbuNaXqAMHxmJlsqH72z7pL-zG7N_XRpR3yeVSA8130_provenance.